New test can predict cancer up to 13 years

Buy Lab Tests Online

Vince

Super Moderator
By Sarah Knapton, Science Editor12:00AM BST 01 May 2015

Genetic changes can predict cancer up to 13 years in the future, according to new research.

Harvard and Northwestern University discovered that tiny but significant changes are already happening in the body more than a decade before cancer is diagnosed.

They found that the protective caps on the ends of chromosomes, which prevent DNA damage, had significantly more wear and tear in people who went on to develop cancer. In fact, in some cases they looked 15 years older.

Those caps, known as telomeres, were much shorter than they should be and continued to get shorter until around four years before the cancer developed, when they suddenly stopped shrinking. All the people with the changes went on to develop cancer.

"Understanding this pattern of telomere growth may mean it can be a predictive biomarker for cancer," said Dr. Lifang Hou, the lead study author and a professor of preventive medicine at Northwestern University Feinberg School of Medicine.

"Because we saw a strong relationship in the pattern across a wide variety of cancers, with the right testing these procedures could be used to eventually diagnose a wide variety of cancers."
Although many people may not want to know that they will develop cancer in the future, it could allow them to make lifestyle changes to lower their risk. Stanford University is also working on a project looking at how telemores can be regrown.
However insurance companies warned that such a test could push up policy premiums.
Matt Sanders, in charge of protection insurance products at GoCompare, said people with such a diagnoses could be priced out of the insurance marker.
“If this test showed 100 per cent probability over a certain number of years then it could affect premiums. It would be the equivalent of living in a high theft area for someone looking for home insurance,” he said.
“Premiums could rise to a point where some people would simply be priced out. However if it was shown that diagnosing earlier could prevent cancer then that could bring down premiums.”
Aviva also said that continually monitored advances in medical sciences ‘ to ensure they are reflected in the premiums paid by our customers, where appropriate.’
In the new study, scientists took multiple measurements of telomeres over a 13-year period in 792 persons, 135 of whom were eventually diagnosed with different types of cancer, including prostate, skin, lung and leukaemia.
Initially, scientists discovered telomeres aged much faster, indicated by a more rapid loss of length, in individuals who were developing but not yet diagnosed with cancer.
Telomeres in all the people who went on to develop cancer looked as much as 15 years older than those of people who were not developing the disease.
But then scientists found the accelerated aging process stopped three to four years before the cancer diagnosis.
Telomeres shorten every time a cell divides. The older a person is, the more times each cell has divided, and the shorter their telomeres.
Because cancer cells divide and grow rapidly, scientists would expect the cell would get so short it would self-destruct. But that's not what happens, scientists discovered.
“We found cancer has hijacked the telomere shortening in order to flourish in the body,” added Dr Hou.
The team is hoping that if it can identify how cancer hijacks the cell, then treatments could be developed to cause cancer cells to self-destruct without harming healthy cells.
http://www.telegraph.co.uk/news/115...r-up-to-13-years-before-disease-develops.html
 
Defy Medical TRT clinic doctor
Wow - very interesting! Especially since it is so often the case that one is only diagnosed with cancer when it is well established and past the best time to treat it...
 
This is very exciting. I had cancer (Lymphoma) two years ago while I designed ExcelMale.com to keep myself sane of mind. It is in remission now but I have to go for check ups once per year. This test would same me time and trouble.


"The hope is that a simple blood draw — far less onerous for patients than a traditional biopsy or a CT scan — will enable oncologists to quickly figure out whether a treatment is working and, if it is, to continue monitoring the treatment in case the cancer develops resistance. Failing treatments could be abandoned quickly, sparing patients grueling side effects and allowing doctors to try alternatives."

New Blood Test Shows Promise in Cancer Fight
 
The Times article requires a login. Is this the source paper?
NEJM: Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Although the combo therapy is offering statistically significant improvement over the monotherapy (11.5 vs. 2.9 months), the sobering truth is that this breakthrough is merely less appalling in terms of survival time. Furthermore, these meds are admitted as being inflammatory (which is apparently considered unimportant on the failed somatic theory of cancer, but is probably going to cause new cancers on the metabolic theory - if you live that long).

The SoC (Standard of Care) for most cancers offers precious little life extension, but does assure that you will be miserable and broke.

These advances are sometimes worthwhile. It would be even more interesting to have included a couple of more cohorts in the trial: a group doing KD-R perhaps with exogenous ketones and HBO2 or H2O2 only, and a group doing that with combo.
 
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

bodybuilder test discounted labs
cheap enclomiphene
TRT in UK Balance my hormones
Discounted Labs
Testosterone Doctor Near Me
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
BUY HCG CIALIS

Online statistics

Members online
6
Guests online
7
Total visitors
13

Latest posts

Top